SCHEMBL10104681

SCHEMBL10104681

C=C1c2[nH]c(-c3cn(Cc4cccc(C(F)(F)F)c4)nn3)nc2N(C)C(=O)N1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.47
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
KCNH2 Q12809 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
KDR P35968 1/20 0.42
TEK Q02763 1/20 0.42
ADORA2B P29275 14/20 0.42
ADORA2A P29274 10/20 0.42
ADORA3 P0DMS8 9/20 0.42
ADORA1 P30542 9/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PLK4 O00444 1/20 0.39
CDK2 P24941 1/20 0.39
IRAK1 P51617 1/20 0.39
RPS6KA3 P51812 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904089 0.76 ADORA2B (0.55) GPR55PSEN1PSEN2KCNH2APH1B
SCHEMBL9903991 0.76 ADORA2A (0.72) GPR55ADORA2BADORA2AADORA3ADORA1
SCHEMBL9904084 0.74 ADORA2B (0.73) ADORA2BADORA2AADORA3ADORA1PLK4
SCHEMBL9903992 0.73 ADORA2B (0.72) ADORA2BADORA2AADORA3ADORA1PLK4
SCHEMBL9904195 0.73 ADORA2B (0.73) ADORA2BADORA2AADORA3ADORA1PLK4
SCHEMBL9904033 0.72 ADORA2B (0.75) ADORA2BADORA2AADORA3ADORA1PLK4
SCHEMBL9904021 0.71 ADORA2B (0.60) ADORA2BADORA2AADORA3ADORA1PLK4
SCHEMBL1231556 0.69 GPR55 (0.71) GPR55PSEN1PSEN2KCNH2APH1B
SCHEMBL9904085 0.68 MAOB (0.59) GPR55PSEN1PSEN2KCNH2APH1B
SCHEMBL16401703 0.68 GPR55 (0.55) GPR55PSEN1PSEN2KCNH2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed